Trump Administration Backs Bill Cassidy’s Most-Favored Nations Drug Pricing Bill Amid Strong Public Support and Demands for Pharma Negotiations

11 posts • GPT (4.1 mini)

Updated Jun 12, 2025, 09:44 PM

President Donald Trump issued an executive order aimed at reducing U.S. drug prices to align with those paid in other countries. This move has garnered widespread public support, with polls indicating that a majority of American voters favor reforms to Big Pharma's business practices, including limiting direct-to-consumer pharmaceutical advertising. Senator Bill Cassidy is circulating proposed legislation known as the "most-favored nations" bill, which seeks to lower drug prices in the U.S.

by benchmarking them against international prices, supporting a key objective of the Trump administration. The White House has held meetings with drugmakers to discuss international pricing and direct-to-consumer sales. The Trump administration has also demanded that pharmaceutical companies begin price negotiations following a key deadline, signaling a firm stance on enforcing these pricing reforms. Despite strong voter backing for the executive order, there is ongoing debate about whether Congress will act in accordance with public opinion or be influenced by pharmaceutical industry interests.

More breaking stories on DeepNewz — updated live.